|
⚲
|
| Keyboard |
| Interact Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002107143 |
| Sale | 2026-07-20 (2.0 M Offered, 0.2 M Sold) |
| Fund | |
| Phone | 2107102867 |
| Address | 3060 Pegasus Park Drive Dallas, TX 75247 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-07-21 (D) |
| Exemption | 506(b) |
| Remaining | $1,750,000 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Isaac Chan | Director | |
| Daniel Hargrove | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Goff Focused Strategies LLC
✚
|
TX | |
|
Next Coast Ventures LLC
✚
|
TX | |
|
Caymus Capital Partners LP
✚
|
TX | |
|
Tolleson Private Bank
✚
|
TX | |
|
Crow Holdings Partners LLC
✚
|
TX | |
|
Paragon JV Partners LLC
✚
|
TX | |
|
Siltstone Capital LLC
✚
|
TX | |
|
Endure Capital Management LLC
✚
|
TX | |
|
Congruent Investment Partners LLC
✚
|
TX | |
|
Cortex Capital Management LLC
✚
|
TX |